Trendlines Group (SG:42T) has released an update.
Trendlines Group Ltd. has released its unaudited financial statements for the first half of 2024 and announced an upcoming Special General Meeting to discuss a new share subscription proposal. The company also highlighted the approval of investments in nine portfolio companies, with key achievements such as Arcuro Medical’s milestone in surgical cases and Nasotrak Medical’s patent grant and certification. Additionally, BeCapio Ltd. has welcomed a new Chair to its board.
For further insights into SG:42T stock, check out TipRanks’ Stock Analysis page.
